Response to: 'Circulating microbiome in blood of different circulatory compartments' by Schierwagen et al
- PMID: 30954950
- DOI: 10.1136/gutjnl-2019-318601
Response to: 'Circulating microbiome in blood of different circulatory compartments' by Schierwagen et al
Keywords: intestinal bacteria; intestinal microbiology; liver; molecular biology.
Conflict of interest statement
Competing interests: EJK performed research for Cubist, Novartis and Qiagen, and participated in advisory forums of Astellas, Optimer, Actelion, Pfizer, Sanofi Pasteur and Seres Therapeutics. BVHH and EJK received an unrestricted grant from Vedanta Biosciences Inc. The companies and the Netherlands Donor Feces Bank had no role in writing the manuscript.
Comment in
-
Trust is good, control is better: technical considerations in blood microbiome analysis.Gut. 2020 Jul;69(7):1362-1363. doi: 10.1136/gutjnl-2019-319123. Epub 2019 Jun 15. Gut. 2020. PMID: 31203205 Free PMC article. No abstract available.
Comment on
-
Circulating microbiome in blood of different circulatory compartments.Gut. 2019 Mar;68(3):578-580. doi: 10.1136/gutjnl-2018-316227. Epub 2018 Mar 26. Gut. 2019. PMID: 29581241 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources